Document detail
ID

oai:pubmedcentral.nih.gov:9835...

Topic
Review Article
Author
Bonnekoh, Hanna Krause, Karoline Kolkhir, Pavel
Langue
en
Editor

Dustri-Verlag Dr. Karl Feistle

Category

Allergologie Select

Year

2023

listing date

10/10/2023

Keywords
symptoms rash urticarial uv
Metrics

Abstract

Chronic urticarial rash, mostly due to chronic spontaneous urticaria (CSU), is seen in up to 1 – 4% of the general population.

Urticarial vasculitis (UV) and autoinflammatory syndromes, i.e., cryopyrin-associated periodic syndromes (CAPS) and Schnitzler syndrome (SchS), can mimic CSU-like rash but represent rare disorders with systemic symptoms including fever, headache, conjunctivitis, and arthralgia.

Clinical and laboratory features can point to the presence of any of these diseases in patients initially presenting with chronic urticarial rash.

These include long-lasting wheals (> 24 hours), lesional burning, systemic symptoms, and/or increase in inflammatory markers (e.g., C-reactive protein, serum amyloid A, and/or S100A8/9).

Lesional skin biopsy usually demonstrates leukocytoclastic vasculitis (UV) or neutrophil-rich infiltrate (CAPS and SchS).

In contrast to CSU, where second-generation H1 antihistamines and omalizumab allow to control symptoms in most patients, systemic immunosuppression and anti-interleukin (IL)-1 therapies are needed in case of UV and autoinflammatory diseases, respectively.

The rarity and low awareness of CSU differential diagnoses may be related to the longer delays in diagnosis and therapy in those affected with UV, CAPS, and SchS.

Knowledge of the differential diagnoses of CSU is important because only correct diagnosis allows adequate therapy.

Complications such as the development of lymphoproliferative disease in SchS and amyloidosis in CAPS, and the presence of comorbid diseases, such as systemic lupus erythematosus in UV, must be considered and monitored.

Bonnekoh, Hanna,Krause, Karoline,Kolkhir, Pavel, 2023, Chronic recurrent wheals – If not chronic spontaneous urticaria, what else? , Dustri-Verlag Dr. Karl Feistle

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature
non-small-cell lung cancer bone metastasis radiomics risk factor predict cohort model cect cancer prediction 0 metastasis radiomics clinical